Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

KTTAKTTA
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in PASITHEA THERAPEUTICS CORP

JPMORGAN CHASE & CO holds 150 shares of KTTA (PASITHEA THERAPEUTICS CORP), worth $79 as of 2026-Q2.

Current Value

$79

Current Shares

150

Total Value Change

-$394

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
150
0.0%
$790.0%$0.52
0
2026-Q1
Unchanged
150
0.0%
$1070.0%$0.80
0
2025-Q4
Decreased
150
-50.0%
$1940.0%$1.15
0
2025-Q3
Increased
300
+100.0%
$2160.0%$0.72
12
2025-Q2
Unchanged
150
0.0%
$1080.0%$0.76
0
2025-Q1
Unchanged
150
0.0%
$1950.0%$1.34
0
2024-Q4
New
150
-
$4730.0%$2.95
17

Other major holders of KTTA: Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C., AMERIPRISE FINANCIAL INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used